Covered recipient · General Payments record
GHAZAL AHMAD
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2021–2024
$2,115.10
- Reported across 59 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $877.85 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $244.77 | 9 |
| ABBVIE INC. | $167.31 | 3 |
| Alexion Pharmaceuticals, Inc. | $156.61 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $92.84 | 1 |
| Amgen Inc. | $52.30 | 2 |
| SK Life Science, Inc. | $48.61 | 2 |
| Teva Pharmaceuticals USA, Inc. | $26.29 | 1 |
| Merz Pharmaceuticals, LLC | $24.83 | 1 |
| ITF Therapeutics LLC | $24.10 | 1 |
| BIOCODEX, INC. | $21.50 | 1 |
| Azurity Pharmaceuticals, Inc. | $18.69 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.79 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103183622 | CMS |
| ABBVIE INC. | $125.00 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103183624 | CMS |
| ABBVIE INC. | $26.52 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103183626 | CMS |
| Alexion Pharmaceuticals, Inc. | $108.80 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1094004886 | CMS |
| Alexion Pharmaceuticals, Inc. | $28.97 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093893932 | CMS |
| Alexion Pharmaceuticals, Inc. | $18.84 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093919346 | CMS |
| Amgen Inc. | $24.63 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111510839 | CMS |
| Amgen Inc. | $27.67 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117490456 | CMS |
| Azurity Pharmaceuticals, Inc. | $18.69 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134002074 | CMS |
| BIOCODEX, INC. | $21.50 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146420558 | CMS |
| ITF Therapeutics LLC | $24.10 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082127735 | CMS |
| Merz Pharmaceuticals, LLC | $24.83 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137949394 | CMS |
| Novartis Pharmaceuticals Corporation | $92.84 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086662599 | CMS |
| SK Life Science, Inc. | $24.14 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154153361 | CMS |
| SK Life Science, Inc. | $24.47 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154153399 | CMS |
| Teva Pharmaceuticals USA, Inc. | $26.29 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151752560 | CMS |
| UCB, Inc. | $22.60 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143332068 | CMS |
| UCB, Inc. | $32.43 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143332073 | CMS |
| UCB, Inc. | $29.23 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143332077 | CMS |
| UCB, Inc. | $30.49 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143332082 | CMS |
| UCB, Inc. | $19.22 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143332086 | CMS |
| UCB, Inc. | $25.11 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143332090 | CMS |
| UCB, Inc. | $30.66 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143332095 | CMS |
| UCB, Inc. | $28.46 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143332098 | CMS |
| UCB, Inc. | $26.57 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143332102 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.